Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

60 mg dose ticagrelor provides stronger platelet inhibition than clopidogrel in Chinese patients with chronic coronary syndrome: A randomized, single-blind, crossover study

Meijiao He,Yun Zhang, Wei Yan,Guangzhong Liu,Danghui Sun,Yue Yuan,Jing Shi,Yihui Kong,Yue Li

Thrombosis Research（2020）

Cited 5|Views7
No score
Abstract
•This was a randomized, single-blind, cross-over study in Chinese patients.•Ticagrelor exhibits more potent antiplatelet aggregation compared with clopidogrel.•60 mg QD ticagrelor had a stronger inhibitory effect than clopidogrel.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined